197 related articles for article (PubMed ID: 35714574)
1. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: A systematic review.
Fadel MG; Ahmed M; Malietzis G; Pellino G; Rasheed S; Brown G; Tekkis P; Kontovounisios C
Cancer Treat Rev; 2022 Sep; 109():102419. PubMed ID: 35714574
[TBL] [Abstract][Full Text] [Related]
2. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
[TBL] [Abstract][Full Text] [Related]
3. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
[TBL] [Abstract][Full Text] [Related]
4. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II).
PelvEx Collaborative
BJS Open; 2021 May; 5(3):. PubMed ID: 34089596
[TBL] [Abstract][Full Text] [Related]
7. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
8. The role of intraoperative radiotherapy in advanced rectal cancer: a meta-analysis.
Fahy MR; Kelly ME; Power Foley M; Nugent TS; Shields CJ; Winter DC
Colorectal Dis; 2021 Aug; 23(8):1998-2006. PubMed ID: 33905599
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
10. Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.
Stijns RCH; de Graaf EJR; Punt CJA; Nagtegaal ID; Nuyttens JJME; van Meerten E; Tanis PJ; de Hingh IHJT; van der Schelling GP; Acherman Y; Leijtens JWA; Bremers AJA; Beets GL; Hoff C; Verhoef C; Marijnen CAM; de Wilt JHW;
JAMA Surg; 2019 Jan; 154(1):47-54. PubMed ID: 30304338
[TBL] [Abstract][Full Text] [Related]
11. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
[TBL] [Abstract][Full Text] [Related]
12. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
14. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
15. Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence.
Elliot AH; Othman BN; Suzuki C; Blomqvist L; Martling A; Johansson H; Glimelius B; Nilsson PJ; Iversen H
Anticancer Res; 2021 May; 41(5):2459-2465. PubMed ID: 33952471
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.
Sorrentino L; Belli F; Valvo F; Villa S; Guaglio M; Scaramuzza D; Gronchi A; Di Bartolomeo M; Cosimelli M
Surg Oncol; 2020 Dec; 35():89-96. PubMed ID: 32858390
[TBL] [Abstract][Full Text] [Related]
18. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
19. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.
Shaikh I; Askari A; Ourû S; Warusavitarne J; Athanasiou T; Faiz O
Int J Colorectal Dis; 2015 Jan; 30(1):19-29. PubMed ID: 25367179
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.
Marin G; Suárez J; Vera R; Balén E; Viudez A; Mata E
Int J Surg; 2017 Aug; 44():15-20. PubMed ID: 28583894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
